Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack D Bui

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2006
IFN-dependent down-regulation of the NKG2D ligand H60 on tumorsJack D Bui, Leonidas N Carayannopoulos, Lewis L Lanier, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2018
Siglec-7 engagement by GBS β-protein suppresses pyroptotic cell death of natural killer cellsJerry J Fong, Chih-Ming Tsai, Sudeshna Saha, et al.
The American Journal of Pathology|October 15, 2014
uPAR induces expression of transforming growth factor β and interleukin-4 in cancer cells to promote tumor-permissive conditioning of macrophagesJingjing Hu, Minji Jo, Boryana M Eastman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 2, 2009
The host defense peptide cathelicidin is required for NK cell-mediated suppression of tumor growthAmanda S Büchau, Shin Morizane, Janet Trowbridge, et al.
Cell Reports|May 6, 2014
Interleukin-17D mediates tumor rejection through recruitment of natural killer cellsTimothy O'Sullivan, Robert Saddawi-Konefka, Emilie Gross, et al.
Immunology|January 29, 2013
The nuclear factor-κB pathway down-regulates expression of the NKG2D ligand H60a in vitro: implications for use of nuclear factor-κB inhibitors in cancer therapyCarlos Peinado, Xi Kang, Chanae Hardamon, et al.
Translational Oncology|June 26, 2025
Mammary tissue microbiome analysis in PyMT mice reveals Methylobacteria as a commensal organism with potential therapeutic applicationsAlfred A Chan, Christine Caron, Marian Navarrete, et al.
Journal for Immunotherapy of Cancer|May 15, 2023
Dual receptor T cells mediate effective antitumor immune responses via increased recognition of tumor antigensHyun J Jang, Christine Caron, Calvin K Lee, et al.
Scientific Reports|September 14, 2018
Interleukin-17D and Nrf2 mediate initial innate immune cell recruitment and restrict MCMV infectionRuth Seelige, Robert Saddawi-Konefka, Nicholas M Adams, et al.
Oncoimmunology|December 15, 2018
Identification and editing of stem-like cells in methylcholanthrene-induced sarcomasEmilie T E Gross, Carlos D Peinado, Yujin Jung, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2006
IFN-dependent down-regulation of the NKG2D ligand H60 on tumorsJack D Bui, Leonidas N Carayannopoulos, Lewis L Lanier, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2018
Siglec-7 engagement by GBS β-protein suppresses pyroptotic cell death of natural killer cellsJerry J Fong, Chih-Ming Tsai, Sudeshna Saha, et al.
The American Journal of Pathology|October 15, 2014
uPAR induces expression of transforming growth factor β and interleukin-4 in cancer cells to promote tumor-permissive conditioning of macrophagesJingjing Hu, Minji Jo, Boryana M Eastman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 2, 2009
The host defense peptide cathelicidin is required for NK cell-mediated suppression of tumor growthAmanda S Büchau, Shin Morizane, Janet Trowbridge, et al.
Cell Reports|May 6, 2014
Interleukin-17D mediates tumor rejection through recruitment of natural killer cellsTimothy O'Sullivan, Robert Saddawi-Konefka, Emilie Gross, et al.
Immunology|January 29, 2013
The nuclear factor-κB pathway down-regulates expression of the NKG2D ligand H60a in vitro: implications for use of nuclear factor-κB inhibitors in cancer therapyCarlos Peinado, Xi Kang, Chanae Hardamon, et al.
Translational Oncology|June 26, 2025
Mammary tissue microbiome analysis in PyMT mice reveals Methylobacteria as a commensal organism with potential therapeutic applicationsAlfred A Chan, Christine Caron, Marian Navarrete, et al.
Journal for Immunotherapy of Cancer|May 15, 2023
Dual receptor T cells mediate effective antitumor immune responses via increased recognition of tumor antigensHyun J Jang, Christine Caron, Calvin K Lee, et al.
Scientific Reports|September 14, 2018
Interleukin-17D and Nrf2 mediate initial innate immune cell recruitment and restrict MCMV infectionRuth Seelige, Robert Saddawi-Konefka, Nicholas M Adams, et al.
Oncoimmunology|December 15, 2018
Identification and editing of stem-like cells in methylcholanthrene-induced sarcomasEmilie T E Gross, Carlos D Peinado, Yujin Jung, et al.
Pageof 8